At Johnson & Johnson, inspired by Our Credo, we use our scale and resources for good, contributing to many causes and initiatives around the world to help advance health and improve people’s lives—both on a global level and at local levels—through targeted initiatives providing local support, engaging employees in our communities, supporting them in the case of emergencies, and donating products for a range of needs.
Our community giving and social impact programs are funded and supported through a variety of entities:30
- Our Global Community Impact partnerships and other strategic charitable initiatives via the Johnson & Johnson Foundation;
- The Johnson & Johnson Patient Assistance Foundation;
- The Johnson & Johnson Corporate Citizenship Trust;
- Various corporate functional divisions and operating companies across our three business segments around the world;
- Employee volunteering and (often matched) fundraising for local causes;
- Product donations.
Community Disaster Preparedness and Relief
Johnson & Johnson strives to be a trusted community partner, including in times of crisis. In the immediate aftermath of any major disaster, we work with international relief partners and local affiliates to assess and rapidly respond—in many cases within hours—to critical health needs with an array of consumer, pharmaceutical and medical products. Through partners such as Heart to Heart International, MAP International and Americares, we deliver emergency medicine and relief supplies to families affected by these events. In 2018, we leveraged the Johnson & Johnson network and passion of employees in times of crisis to provide immediate aid to communities affected by natural disasters working with six partners. More than $11 million in cash and products were donated to support the disaster response efforts in countries including Bangladesh, India, Indonesia, Kenya, Liberia, Peru, Turkey, South Somalia, the United States and Yemen.
We support our employees who volunteer to assist when disaster strikes. In 2018, we created a new First Responder Time-Off Policy, allowing employees who serve as Emergency Volunteer Workers to take up to 40 hours a year of paid time off if an emergency summons requires the employee to be late or absent from work. Employees are also able to leave work to respond to the summons as needed. The policy currently applies to employees in the United States and Puerto Rico.
In the event of a disaster, the Johnson & Johnson Crisis Management Team, comprised of many cross-functional teams across the Enterprise, ensures coordination and alignment to meet our commitment to the safety and wellbeing of our employees and their families, and to ensure our products get to where they are needed most. To that end, we work together toward preparedness, prevention, response, and quick recovery following a crisis.
We work with trusted partners on the front lines of care to help communities by coordinating product donations, and through programs that help communities recover, rebuild and become resilient.
In 2018, we allocated $0.86 million in cash and $10.43 million worth of Johnson & Johnson products in support for immediate, mid- and long-term response to natural disasters, including Syria refugee crisis, hurricanes Harvey, Maria, Michael and Florence, earthquake and tsunami in Indonesia, among others.
Globally, we aim to support patients and our partners in every way we can, and that includes non-cash contributions. As one of the first companies to sign the WHO Guidelines for Donated Drugs, and as a founding member of the Partnership for Quality Medical Donations (PQMD), Johnson & Johnson ensures that all its product donations follow global standards and best practices. We work with the PQMD to further strengthen their product donation guidelines.
We have longstanding relationships with strategic partners who have proven track records in product donations for disaster relief and for specific health conditions in low- and middle-income countries. Product donations managed by these partners align closely with the conditions for product donation recommended by WHO and PQMD, and with industry requirements and regulations. In the United States, we also support independent initiatives by donating medicines and funding to the Johnson & Johnson Patient Assistance Foundation Inc. (JJPAF), an independent, nonprofit organization that is committed to helping eligible patients without insurance coverage receive prescription products donated by Johnson & Johnson operating companies.
In 2018, we donated $987 million in free product and financial support to JJPAF, enabling the Foundation to provide medicines at no cost to approximately 76,000 patients.
|Total cash and product contributed globally (in millions)||$1,612||$1,469||$1,194|
|Non-cash contributed globally (in millions)*||$1,299||$1,242||$1,006|
|Cash contributed globally (in millions)**||$313||$227||$188|
** Cash contributed globally includes $23 million contributed by the Johnson & Johnson Foundation through the U.S. Employee Matching Gifts Program in 2018.